Skip to main content

Modulation of Taurine on CYP3A4 Induction by Rifampicin in a HepG2 Cell Line

  • Chapter
Taurine 5

Abstract

There has recently been an increased demand for nutritional supplements and health drinks containing taurine. The Japanese diet also provides high levels of taurine. In addition, 60% of the over-the-counter (OTC) drugs classified as vitamin-mixture medication contain taurine (Figure 1). Because taurine intake is so high, there has been concern that it might interact with other drugs. A common form of drug-drug interaction involves the induction or inhibition of specific drug-metabolizing enzymes such as cytochrome P450 (CYP)1. However, little is known about the influence of taurine on the metabolism of clinically important drugs. The antibiotics rifampicin (RFP) is a strong CYP3A4 inducer in humans2. In the present study we examined whether taurine could affect the levels of CYP3A4 mRNA in the presence and absence of RFP.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chiba, H., 1995, Drug interaction via cytochrome P450. FARUMASHIA, 31, 922–996.

    Google Scholar 

  2. Venkatesan, K., 1992, Pharmacokinetic drug interactions with rifampicinClin. Pharmacokinet.22, 47–65.

    Article  PubMed  CAS  Google Scholar 

  3. DRUGS IN JAPAN OTC-DRUGS 12ed. 2000–02, 2000, Japan Pharmaceutical Information Center, ed., JIHO, Tokyo, pp449–571.

    Google Scholar 

  4. Sumida, A., Fukuen, S., Yamamoto, I., Matsuda, H., Naohara, M. and Azuma, J. 2000, Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription-competitive PCR.Biochem. Biophys. Res. Commun.267,756–760.

    Article  PubMed  CAS  Google Scholar 

  5. Ohwada, S., Kishi, F., Hayashi, N., and Takada, M., 1994, The enhancement of rectal absorption of rifampicin by sodium p-aminosalicylic acid in a human.Yakugaku zasshi114, 894–900.

    PubMed  Google Scholar 

  6. Jones, B.N. and Gilligan, J.P., 1983, o-Phthaldialdehyde precolumn derivatization and reversed-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluids.J. Chromatogr.266, 471–482.

    Article  PubMed  CAS  Google Scholar 

  7. Labudova, O., Yeghiazarjan, C., Hoger, H., Lubec, G., 1999, Taurine modulates expression of transporters in rat brain and heart.Amino Acids.17,301–313.

    Article  PubMed  CAS  Google Scholar 

  8. Bitoun, M., Tappaz, M., 2000, Taurine down-regulates basal and osmolarity-induced gene expression of its transporter, but not the gene expression of its biosynthetic enzymes, in astrocyte primary cultures.J. Neurochem.75,919–924.

    Article  PubMed  CAS  Google Scholar 

  9. Moenkemann, H., Labudova, O., Yeghiazarian, K., Rink, H., Hoeger, H., Lubec, G., 1999, Evidence that taurine modulates osmoregulation by modification of osmolarity sensor protein ENVZ--expression.Amino Acids.17,347–355.

    Article  PubMed  CAS  Google Scholar 

  10. Kolars, J.C., Schmiedlin-Ren, P., Schuetz, J.D., Fang, C. and Watkins, P.B., 1992, Identification of rifampin-inducible P450111A4 (CYP3A4) in human small bowel enterocytes.J. Clin. Invest.90,1871–1878.

    Article  PubMed  CAS  Google Scholar 

  11. Muntane-Relat, J., Ourlin, J.C., Domergue, J. and Maurel, P., 1995, Differential effects of cytokines on the inducible expression of CYPIAl, CYPIA2, and CYP3A4 in human hepatocytes in primary culture.Hepatology22,1143–1153.

    Article  PubMed  CAS  Google Scholar 

  12. Sumida, A., Kinoshita, K., Fukuda, T., Matsuda, H., Yamamoto, l., Inaba, T. and Azuma, J. 1999, Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver.Biochem. Biophys. Res. Commun.262,499–503.

    Article  PubMed  CAS  Google Scholar 

  13. Schuetz, E.G., Schuetz, J.D., Strom, S.C., Thompson, M.T., Fisher, R.A., Molowa, D.T., Li, D. and Guzelian, P.S., 1993, Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes.Hepatology. 181254-.

    Article  PubMed  CAS  Google Scholar 

  14. Kliewer, S.A., Moore, J.T., Wade, L., Staudinger, J.L., Watson, M.A., Jones, S.A., McKee, D.D., Oliver, B.B., Willson, T.M., Zetterstrom, R.H., Perlmann, T. and Lehmann, J.M.,1998, An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway.Cell92,73–82.

    Article  PubMed  CAS  Google Scholar 

  15. Lehmann, J.M., McKee, D.D., Watson, M.A., Willson, T.M., Moore, J.T.and Kliewer, S.A., 1998, The human orphan nuclear receptor PXR is activated by compounds that regulateCYP3A4 gene expression and cause drug interactions.J. Clin. Invest.102,1016–1023.

    Article  PubMed  CAS  Google Scholar 

  16. Pascussi, J.M., Drocourt, L., Fabre, J.M., Maurel, P. and Vilarem, M.J., 2000, Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators.Mol. Pharmacol.58,361–372.

    PubMed  CAS  Google Scholar 

  17. SueyosJii, T. and Negishi, M., 2001, Phenobarbital response elements of cytochrome P450 genes and nuclear receptors.Annu. Rev. Pharmacol. Toxicol.41,123–143.

    Article  Google Scholar 

  18. Waxman, D.J.,1999, P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR.Arch. Biochem. Biophys.369,11–23.

    Article  PubMed  CAS  Google Scholar 

  19. Stieger, B., Fattinger, K., Madan, J., Kullak-Ublick, G.A. and Meier, P.J., 2000, Drug-and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.Gastroenterology.118,422–430.

    Article  PubMed  CAS  Google Scholar 

  20. Hardison, W.G.and Proffitt, J.H., 1977, Influence of hepatic taurine concentration on bile acid conjugation with taurine.Am. J. Physiol.232,E75–E79.

    PubMed  CAS  Google Scholar 

  21. Hardison, W.G., 1978, Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine.Gastroenterology75,71–7.5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Takahashi, K. et al. (2003). Modulation of Taurine on CYP3A4 Induction by Rifampicin in a HepG2 Cell Line. In: Lombardini, J.B., Schaffer, S.W., Azuma, J. (eds) Taurine 5. Advances in Experimental Medicine and Biology, vol 526. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0077-3_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0077-3_30

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4913-6

  • Online ISBN: 978-1-4615-0077-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics